A Moderate to Severe Rheumatoid Arthritis Study

Clinical trial NCT01721044 · COMPLETED

Trial details

NCT number: NCT01721044
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2013-01-01
Primary completion: 2014-06-01
Enrollment: 527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.